Colorectal cancer develops from the accumulation of mutations in tumor suppressor genes, proto-oncogenes and genes that affect DNA repair (Kinzler and Vogelstein, 1996) . One of the earliest mutations in the development of most colorectal tumors occurs in the APC tumor suppressor gene, which encodes a multifunctional protein involved in the Wnt/Wingless signaling pathway (Goss and Groden, 2000) . Loss of APC function in the cell leads to an accumulation of the cell adhesion and signaling molecule b-catenin, which then translocates to the nucleus and alters the expression of genes involved in cell growth (Behrens et al., 1996; Huber et al., 1996) . Although the biochemistry of APC and its role in Wnt signaling are fairly well understood, the varied effects of APC and its isoforms on cell growth, death and differentiation are still unclear.
The conventional APC (cAPC) splice form is present in many cell types, while other APC splice forms are present only in differentiated cells (Groden et al., 1991) . These alternative splice forms exclude exon 1 but include alternate exons 5 0 of the missing exon 1. Two of the splice variants, BS (brain-specific) APC and 0.3 (exon 0.3) APC, contain in-frame translation initiation codons allowing for removal of the conventional exon 1 with its initiating ATG. Consequently, BS APC and 0.3 APC proteins lack an apparent exon 1-encoded homodimerization domain (Santoro and Groden, 1997; Pyles et al., 1998) . These protein isoforms are prominent in neuronal cells and other tissues rich in nondividing cell populations. Interestingly, induction of differentiation in a murine cell line also leads to an increased expression of APC transcripts that lack exon 1 but include various nonconventional 5 0 exons (Santoro and Groden, 1997) . These data suggest that the expression of alternate APC isoforms or the switch in isoform type may play a role in differentiation or exit from the cell cycle. In this study, we examine the effects of three isoforms of APC on cell morphology, protein localization, cell growth, tumorsuppressing activity and their ability to regulate b-catenin.
A mammalian transcription regulatory system, which utilizes the bacterial tetracycline resistance operator/ repressor, was used to control the expression of APC (Gossen, 1992) . The SW480 cancer line was chosen since it does not express full-length APC. A plasmid expressing the tTA transactivator was transfected into SW480 cells and stably transfected clones were identified. Two cell lines were chosen for each APC isoform based on positive APC protein expression in the absence of tetracycline. All lines exhibited a low basal level of the full-length APC even in the presence of tetracycline; however, expression increased for all three APC isoforms upon tetracycline removal (data not shown). Significant changes in cell morphology were observed for all three APC-containing cell lines when compared to the parental line. Cells were larger and flatter than their parental counterparts, with larger and more distinct nuclei (Figure 1 ). Cells expressing each of the APC isoforms often contained micronuclei and exhibited small cytoplasmic granules.
We next examined asynchronous cell cultures to determine if expression of the APC isoforms had any effects on the distribution of cells in the cell cycle. Cells were grown without tetracycline for 48 h and analysed by flow cytometry. Expression of each APC isoform had a substantial effect on the proportion of cells in G1 when compared to the parental line. The cAPC-positive cell lines exhibited an increase in the G1 population of 23%, 0.3 APC cells increased 19%, while the BS APC cells increased 13%. In addition, there were significant decreases in the percentages of cells in S phase (Figure 2a ), suggesting that APC inhibits cell growth by affecting the G1/S transition. Statistical analysis using Dunnett's t-tests revealed that the difference in the percentage of cells in G1 for each of the transfected cell lines is significantly different from the percentage of cells in G1 for the parental cell line. The length of G1 was calculated from the percentage of cells in G1 and the length of the cell cycle or doubling times calculated from the individual cell line data used for the growth curves in Figure 2b . Each of the cell lines expressing an APC isoform showed a longer G1 phase compared to the parental cells. Constitutive expression of each isoform slows the growth rate of the cells by lengthening the G1 phase or by blocking a subpopulation of cells in G1.
At the time of its submission to ATCC, SW480 was capable of establishing colonies in soft agar. This assay is often used as an in vitro measure of the tumorigenic potential. We examined whether each of the APC isoforms, when overexpressed in SW480, could inhibit its ability to grow in soft agar. Cell lines expressing each of the three APC isoforms and the parental line were plated in agar and analysed after 8 weeks ( Figure 2c ). The histogram shows the number of colonies obtained from each cell line as compared to the parental cells (set to 100%). As predicted, cAPC clearly reduced the formation of colonies (6 and 31%) in soft agar, as is characteristic of a functional tumor suppressor. Consistent with this result, BS APC reduced colony growth in soft agar to a comparable level (43 and 13%). However, the 0.3 APC isoform was unable to inhibit growth (109 and 82%) as colonies expressing 0.3 APC grew similar to the SW480 parental cell line. This finding suggests that the 0.3 APC isoform may not act as a tumor suppressor in SW480 and may have a different function than the cAPC and BS APC isoforms.
To investigate this characteristic of the 0.3 APC isoform, we evaluated BrdU incorporation as a separate, additional measure of cell growth. APC constructs were modified by the addition of a gene encoding enhanced green fluorescent protein and transiently transfected into the SW480 cell line. While cAPC and BS APC dramatically reduced BrdU incorporation in GFPpositive cells (18 and 20%, respectively), 0.3 APC was not as effective at reducing BrdU incorporation (31%) in the SW480 cell line (Figure 3a) . S37A-b-catenin, an oncogenic form of the b-catenin protein, was transiently overexpressed with each of the GFP-APC isoforms to test whether the differences in BrdU uptake are present when APC signaling through b-catenin is blocked. Interestingly, S37A-b-catenin over-rides the effects of each APC isoform and returns BrdU incorporation to the same level as the parental cell line (Figure 3a) . To test whether the effect of each APC isoform on BrdU incorporation remains when the oncogenic activity of b-catenin is blocked, a dominant negative TCF (DN67-LEF-1) was used. This TCF/LEF mutant is unable to interact with b-catenin and thus blocks the ability of b-catenin-TCF/LEF-1 to control target gene activity. When each of the three APC splice forms were cotransfected with S37A and DN67-LEF-1, BrdU incorporation for the cAPC-and BS APC-transfected cells decreased more than the 0.3 APC-transfected cells (Figure 3a) . The cancer cell line SW480 was obtained from the ATCC collection. G418 (Life Technologies) was used to select cell clones at a concentration of 400 mg/ml; hygromycin (Roche) -800 mg/ml and tetracycline -2 mg/ml. Transient transfections were performed using Lipofectamine 2000 (Invitrogen). APC constructs were prepared by subcloning a BamHI fragment from APC pBluescript (Groden et al., 1995) into the pUHG 10-3 expression vector (Gossen, 1992) . The 0.3 and BS APC isoforms were cloned using PCR to amplify exons BS-2-9 or 0.3-2-9 from human cerebellum cDNA. Amplified products were inserted into an APC pBluescript and then subcloned into pUHG 10-3. All constructs were tested for their ability to express the full-length APC by transient expression in SW480 cells expressing the VP16-tetracycline transactivator and immunofluorescence with a C-terminalspecific antibody C-20 (Santa Cruz). For stable transfections, plasmid 15-1 neo was transfected into SW480 cells using DOTAP (Roche). Clones were selected in the presence of 0.4 mg/ml active G418 and tested for their ability to induce expression. One cell line, SW480 3-5-5, was chosen for further experiments based on the level of TetR/VP16 expression and its ability to be controlled by tetracycline. Isoform-specific APC constructs were each transfected with 0.5 mg of a TK-hygromycin plasmid into 70% confluent SW 480 3-5-5 cells. Tetracycline (2 mg/ml) was added to the culture medium and clones were selected using 800 mg/ml of hygromycin and G418
One mechanism by which APC promotes growth suppression is by interacting with and downregulating b-catenin. To determine whether the nonconventional APC isoforms affect b-catenin transcriptional activity, we performed TOPFLASH assays to measure b-catenin activity in transiently transfected SW480 cells. Each isoform reduced b-catenin activity similar to that in cells transiently transfected with GFP-cAPC alone Figure 2 Comparison of the SW480 colon cancer cells expressing APC isoforms. (a) Average growth rates of the transfected cell lines compared to the parental SW480 cells. All cell lines were grown in the absence of tetracycline. To determine growth rate, cells were seeded at 2 Â 10 4 cells/well in 24-well plates with or without tetracycline. Three wells were counted on a hemacytometer at 24 h time points for 10 days. Means were calculated and plotted. (b) Effects of APC isoform expression on cell cycle distribution. Each cell clone and the SW480 cell line were grown for 72 h and analysed by flow cytometry. For this analysis, cells were plated onto 60-mmdiameter plates at 50% confluency and grown for 3 days without tetracycline or hygromycin. The cells were trypsinized, resuspended in medium containing 10% FBS, centrifuged, washed and resuspended in 1 ml of 50 mg/ml propidium iodide (Sigma) buffer. Cells were analysed in a FACS (Coulter Epics XL, BeckmanCoulter Corp.) and the percentage of cells in different phases of the cell cycle were determined. (c) Soft-agar colony forming assays. Shown are the percentages of colonies in soft agar compared to the parental cells. For this analysis, cells were plated onto 60-mmdiameter plates at 50% confluency and grown for 3 days without tetracycline or hygromycin. The cells were trypsinized, resuspended in medium containing 10% FBS, centrifuged, washed and resuspended in 1 ml of 50 mg/ml propidium iodide (Sigma) buffer. Cells were analysed in a FACS (Coulter Epics XL, BeckmanCoulter Corp.) and the percentage of cells in different phases of the cell cycle were determined. Cells were trypsinized, counted and resuspended at 2000 cells/60 mm plate. Cells were mixed with 2 ml of plating agar (0.33% plating agar in cell culture medium containing G418 and overlaid on 5 ml of a base containing 0.5% agar in culture medium. Plates were incubated at 371C at 5% CO 2 and cultures were fed every 10 days. Colonies were scored at 8 weeks. Each cell line was assayed six times Transcription activation mediated by b-catenin was assayed using the TOPFLASH system (Promega). Cotransfections were carried out in triplicate and the results of three independent experiments averaged ( Figure 3b) . When S37A-b-catenin is cotransfected with each APC construct, luciferase activity increases similarly in cells expressing any of the three APC isoforms (Figure 3b ). These results suggest that the differences in function between the APC isoforms may be unrelated to transcription.
As each APC isoform similarly reduces b-catenin transcriptional activity, there may be little difference in the ability of each isoform to colocalize and downregulate b-catenin. APC colocalizes with cytoplasmic microtubules (Munemitsu et al., 1994; Smith et al., 1994) . Therefore, colocalization of APC with microtubules was evaluated by immunofluorescence and confocal laser scanning microscopy. A filamentous pattern of APC staining is observed in transiently transfected SW480 cells (Figure 4a-f) . This pattern resembles that of tubulin more closely than that of keratin, using overlays of individual antibody staining patterns . No difference was observed in the ability of the 0.3 APC isoform to colocalize with microtubules as compared to cAPC and BS APC.
The function of APC as a tumor suppressor stems primarily from its ability to regulate cellular levels of the signaling molecule b-catenin (Behrens et al., 1996; Huber et al., 1996) . In the present experiments, we asked whether two other APC protein isoforms play a role in tumor suppression. Unexpectedly, the 0.3 APC isoform is unable to suppress tumorigenicity in a softagar colony-forming assay in contrast to the cAPC and BS APC isoforms. The question of whether b-catenin overexpression alleviates the G1 arrest observed in APC-transfected cell lines was tested previously in transient cotransfection experiments with conventional APC and mutant oncogenic b-catenin (Heinen et al., 2002) . These results demonstrated that entry into S phase was prevented by APC expression and partially released by oncogenic b-catenin. Therefore, it is likely that the increase in cells in G1 overexpressing cAPC, 0.3 APC or BS APC is associated with the interaction of APC and b-catenin, and the hindering of growthpromoting functions of b-catenin.
Tumor suppression by the cAPC isoform may depend upon homodimerization or interaction with another protein mediated through the amino-terminus (Joslyn et al., 1993; Su et al., 1993) . This heptad repeat is encoded by exon 1, which is lacking in the alternative APC isoforms (Santoro and Groden, 1997) . It is unclear In (a-c), APC (red) and tubulin (green) were detected using rhodamine-and FITC-conjugated secondary Abs, respectively. For (d and f), APC (red) and keratin (green) were detected. Overlaid images are shown where yellow represents colocalized staining, all at Â 100 magnification. Methods: APC constructs were transiently transfected into SW480 cells plated onto coverslips. Cells were grown for 48 h, fixed in cold methanol (À201C) for 15 min and washed in Tris-saline. Cells were blocked for 20 min and immunostained with 100 ml of primary antibody, either C-20 (Santa-Cruz) or mouse monoclonal Glu-Glu antibody (BabCO). A mouse monoclonal antibody specific for b-catenin (Transduction Laboratories) and a rabbit monoclonal antibody specific for keratin 8 were also used. The anti-tubulin antibody was rabbit polyclonal antisera anti-Tyr. Coverslips were washed and stained with secondary antibody. The secondary antibodies used for microtubule localization were either a rhodamineconjugated anti-mouse IgG and a FITC-conjugated anti-rabbit IgG or a FITC-conjugated anti-mouse IgG and a rhodamineconjugated anti-rabbit IgG as to whether the BS and 0.3 APC isoforms interact with the cAPC, or with each other, although preliminary studies were negative (Pyles et al., 1998) . Although BS APC lacks the first heptad repeat, it can still suppress the tumorigenic phenotype of SW480 cells, suggesting that the homodimerization domain is not required for this function. The inability of the 0.3 APC isoform to provide this function may then be due to structural characteristics of this protein that alter its ability to interact with other proteins. In addition, the 0.3 APC isoform is less effective at inhibiting cell growth as measured by BrdU incorporation. However, transient transfections show no difference in the subcellular localization patterns and all isoforms cause similar reductions in b-catenin activity in SW480 cells. These findings suggest that the observed difference in the isoforms is not transcriptionally related but rather involves as yet unidentified protein functions of the unique amino-termini.
